Lazard Asset Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Sell |
|
|||||
|
2025
Q1 | $963K | Sell |
|
|||||
|
2024
Q4 | $1.82M | Sell |
|
|||||
|
2024
Q3 | $3.36M | Buy |
|
|||||
|
2024
Q2 | $1.32M | Sell |
|
|||||
|
2024
Q1 | $2.8M | Buy |
|
|||||
|
2023
Q4 | $3.39M | Sell |
|
|||||
|
2023
Q3 | $2.57M | Sell |
|
|||||
|
2023
Q2 | $5.55M | Buy |
|
|||||
|
2023
Q1 | $5.5M | Sell |
|
|||||
|
2022
Q4 | $3.6M | Sell |
|
|||||
|
2022
Q3 | $3.8M | Buy |
|
|||||
|
2022
Q2 | $5.75M | Buy |
|
|||||
|
2022
Q1 | $5.31M | Buy |
|
|||||
|
2021
Q4 | $7.93M | Buy |
|
|||||
|
2021
Q3 | $3.76M | Buy |
|
|||||
|
2021
Q2 | $4.82M | Buy |
|
|||||
|
2021
Q1 | $60K | Buy |
|
|||||
|
2020
Q4 | $44K | Buy |
|